In America's cancer centers, where many patients go for specialized cancer treatment, prostate screening policies do not always align with evidence-based recommendations. More
Mental health apps designed to improve access to care may be driving overdiagnosis and overmedication, a recent investigation finds. More
Lown Institute Analysis Shows Hospitals Are More Equitable When Caring for COVID Patients. More
Do nonprofit hospitals have higher unreimbursed Medicaid costs than for-profit hospitals? More
Why is it equitable to take race into account in healthcare in some cases but not others? The answer lies in the distinction between race and racism. More
Join us March 17 at 1pm as we announce the most racially inclusive hospitals in America, and discuss the impact of Covid on hospital inclusivity. More
A newly-developed metric of low-value prescribing practices helps fill an important gap in the research of overuse metrics. More
As many as 25% of screening colonoscopies are not consistent with national guidelines, according to a recent systematic review. More
Low back pain is one of the most common health problems in the world and one of the most common causes of overuse -- but there is some good news. More
Patient advocates and researchers uncover concerning patterns in financial relationships between industry funding and patient advocacy organizations. More
What are we rewarding hospital CEOs for -- and what metrics could drive their salaries on instead? In an recent piece in Health Affairs Forefront, Vikas Saini, Judith Garber, and Shannon Brownlee from the Lown Institute share findings from the Lown Hospitals Index on pay equity at nonprofit hospitals. More
Deaths in high-income countries have largely become "medicalized," moving more and more into the purview of the health care system. What are the implications of this change for families and for health systems around the world? The Lancet Commission on the Value of Death recently released a report addressing the medicalization of death and why it matters. More
A group of advocates has been sounding the alarm about the risk of side effects from benzodiazepines, even when taken as directed. An upcoming documentary tells their stories. More
Will devices like the Apple Watch that continuously monitor heart rhythm reduce rates of stroke? The evidence still isn't there, the USPSTF finds. More
To reduce harmful overmedication, we need to give doctors and patients opportunities to deprescribe. One pharmacy benefit manager has already started providing prescription checkups for their members -- here's how their program is working so far. More
After CMS restricted access to Aduhelm, Biogen and the Alzheimer's Association called the decision discriminatory. Here's why we're skeptical... More
The Medsafer study shows how clinical decision tools can help doctors deprescribe more in the hospital. More
New research from Johns Hopkins evaluates overuse at more than 600 health systems. How do their results compare to those of the Lown Hospitals Index? More
Enjoy these Shkreli Award "dishonorable mentions" — nominees that didn't quite make the top ten, but are worth calling out nonetheless. More
A recently-released Congressional committee report on drug prices reveals some outrageous business practices by pharma -- here's what they found. More